NPAT up 25.0% but Glassons Australia profit fell as H2 momentum faded

The headline is flattered by H1, which contributed 65.1% of full-year NPAT against a prior comparable that had 5,432 lost Australian trading days from store closures. Implied H2 NPAT of $11.2m trails the prior-year H2 figure of roughly $13.7m.

Within segments, Glassons Australia revenue rose 21.9% to $191.2m but segment profit fell 5.5% to $24.6m. Glassons New Zealand profit jumped to $15.1m from $5.7m and Hallensteins climbed to $5.4m from $2.9m. Operating cash flow grew 29.6% to $68.0m and inventory fell 7.3% to $31.0m.

The dominant segment (47% of group revenue) delivered a 21.9% sales uplift but a 5.5% segment-profit decline, pointing to gross-margin compression or higher operating costs. Management commentary at the half cited a slip in gross margin to 56.5% from 57.9% and the cost-of-living crisis; the FY result suggests that pressure intensified across H2.

Implied H2 earnings ran below the prior comparable. With H1 NPAT up 74.8% against a heavily disrupted base, the full-year 25.0% growth obscures an H2 NPAT that fell to roughly $11.2m from $13.7m. The H2 shape is the more relevant signal for FY24 trading.

Cash quality is strong. Operating cash flow of $68.0m and FCF pre-lease of $53.2m converted at 166.4% of NPAT, supported by a $2.6m working-capital release as inventory days fell from 34.8 to 27.6. Capex stepped up 78% to $14.8m, lifting capex intensity to 3.6% of revenue.

The interim release flagged margin slippage and persistent cost-of-living pressure; the segment numbers suggest both continued into H2, particularly in Australia where revenue scaled but profit did not. Capex stepped up sharply, implying continued investment in distribution and store infrastructure rather than a defensive posture. The release does not disclose like-for-like sales, channel mix, or post-balance-date trading, so the durability of the gross-margin compression into FY24 cannot be calibrated from this filing.

OCF/NPAT exceeded 2.0x, working capital released funds, and ROE strengthened to 33.2% from 28.3%. The full-year ordinary dividend of 48 cents (against 42 cents on the same full-year basis prior) is comfortably covered by free cash flow at a 53.8% FCF payout, though it remains 89.6% of NPAT.

The growth itself is less clean. H1 lapped a heavily disrupted Australian operating period, which mechanically lifted year-on-year comparisons; H2 - the cleaner comparable - showed an Australia segment profit decline despite revenue growth, and an implied NPAT step-down versus the prior-year H2. Tax-rate normalisation explains the 4.3pp gap between PBT growth (29.3%) and NPAT growth (25.0%), so PBT is the cleaner read on operating performance. The inventory drawdown that supported cash conversion will not repeat at the same scale, so OCF growth of 29.6% should not be extrapolated.

This briefing cannot assess segment-level gross margins, like-for-like sales, or post-balance-date trading because none of these are disclosed in the filing.